Description
Ovarian Cancer Surveillance (ROCA Test)
ROCA Care is a comprehensive surveillance package using the ROCA Test. ROCA Care is designed specifically for women who are between 35 and 83 years old who have tested positive for a BRCA1 or BRCA2 gene mutation and who wish to defer risk reducing surgery. It is based on blood samples every 4 months to monitor CA125.
Any woman interested in having surveillance using the ROCA Test should have an initial consultation with a UK consultant, so that she can understand the latest clinical evidence, and gain an informed view on the benefits and risks of using the ROCA Test. During the consultation, the clinician will discuss your risk of ovarian cancer and your suitability for the test. If you wish to go ahead you can have your blood test taken at our Cardiff Clinic or we can arrange a kit to be sent to you for a blood draw at your nearest participating Superdrug or at home. We will then arrange a follow up tele consultation and emailed report when your results are ready.
The ROCA Test blood test should be conducted 3 times a year and you should have an annual review consultation. Sometimes additional blood samples may be required at no additional laboratory cost. More information can be found at www.therocatest.co.uk
ROCA Care is available to any woman throughout the UK. You can have your blood sample in our Cardiff clinic, you can arrange phlebotomy e.g. at participating Superdrug stores or we can arrange it in your own home or workplace via our ROCA Care at Home service anywhere in the UK or Northern Ireland..
You can order online here or by talking to our Customer Care Team on 0345 230 3386
Lines open Monday to Friday, 9am – 4pm
Ovarian Cancer
Ovarian cancer is the fifth most common cause of cancer-related deaths in women, and is often called the “silent killer” because the symptoms can be vague and difficult to diagnose at an early stage, when the survival rate is high.Read more at (ROCA Test) The sooner ovarian cancer can be detected, the earlier it can be diagnosed and treated, increasing the chance for survival.
The ROCA Test
The ROCA Test is a blood test that determines the risk of a woman having ovarian cancer. The test is intended for women with a mutation in the BRCA1 or BRCA2 gene that confers a high risk of developing ovarian cancer. Women with a BRCA1 or BRCA2 gene mutation are generally recommended to consider surgical removal of their ovaries and fallopian tubes. However, this results in early menopause and affects fertility. Hence many women choose to delay this procedure.
Test Results
The ROCA Test reports a numerical score which represents a woman’s risk of having ovarian cancer. With this initial score, a doctor will be able to determine if further tests such as a transvaginal ultrasound scan are needed.
Limitations
Understand the risks, limitations and contraindications of the ROCA Test.
Frequently Asked Questions
Have questions about the ROCA Test? Get more answers here.
